Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | APLNR | P35414 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1931051 | 1.00 | CYP1A2 (0.38) | CYP1A2APLNRALDH1A1LMNAKMT2A | |
| SCHEMBL12535883 | 0.87 | STAT3 (0.37) | APLNRALDH1A1LMNASMN1; SMN2CYP2C19 | |
| SCHEMBL7453168 | 0.87 | STAT3 (0.37) | APLNRALDH1A1LMNASMN1; SMN2CYP2C19 | |
| SCHEMBL6525612 | 0.85 | ATM (0.39) | ALDH1A1KMT2ACYP2C9MEN1MAPT | |
| SCHEMBL1932530 | 0.78 | DGAT1 (0.40) | CA2 | |
| SCHEMBL1932528 | 0.78 | DGAT1 (0.40) | CA2 | |
| SCHEMBL17440865 | 0.76 | IRAK4 (0.37) | — | |
| SCHEMBL5734584 | 0.75 | CA2 (0.40) | CYP1A2APLNRALDH1A1CYP2D6CYP2C9 | |
| SCHEMBL9645747 | 0.75 | PYCR1 (0.38) | CYP1A2APLNRALDH1A1CYP2D6CYP2C9 | |
| SCHEMBL5732344 | 0.74 | CA2 (0.39) | APLNRALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9656986-B2 | Compositions comprising TPGS-750-M | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-9656985-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-20170073322-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-03-16 | — | — | US | disclosed |
| US-20160347677-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MYCELL TECH LLC (US) | 2016-12-01 | — | — | US | disclosed |
| US-20160340332-A1 | Compositions Comprising TPGS-750-M | MYCELL TECH LLC (US) | 2016-11-24 | — | — | US | disclosed |
| US-8785665-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2014-07-22 | — | — | US | disclosed |
| EP-2506970-A1 | SURFACTANT-ENABLED TRANSITION METAL-CATALYZED CHEMISTRY | Mycell Holdings Limited (US) | 2012-10-10 | — | — | EP | disclosed |
| WO-2011068895-A1 | SURFACTANT-ENABLED TRANSITION METAL-CATALYZED CHEMISTRY | MyCell Holdings Limited (US) | 2011-06-09 | — | — | WO | disclosed |
| US-20110130562-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MyCell Holdings Limited | 2011-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160340332-A1 | Compositions Comprising TPGS-750-M | S100A10, S100A6, TPR | CYP1A2 4188/4885APLNR 1733/4885ALDH1A1 4415/4885 |
| US-20170073322-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | CYP1A2 4205/4885APLNR 1301/4885ALDH1A1 3372/4885 |
| US-20110130562-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | CYP1A2 4205/4885APLNR 1301/4885ALDH1A1 3372/4885 |
| US-20160347677-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | CYP1A2 4205/4885APLNR 1301/4885ALDH1A1 3372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.